MGAWN1

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMGAWN1
Drug Alias NamehE16MGAWN 1West Nile virus monoclonal antibody - MacroGenicsMGAWN-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionRecombinant envelope protein inhibitors
TargetsRecombinant envelope protein
Therapy Area/IndicationsParalysisMeningitisEncephalitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMacrogenics Inc
Active IndicationsN/A
Inactive IndicationsParalysisMeningitisEncephalitis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A